Results for tag: "Tropical Disease Drug"

The Tropical Disease Drug market is a subset of the Infectious Diseases Drugs market, focusing on treatments for diseases that are endemic to tropical and subtropical regions. These diseases include malaria, dengue fever, chikungunya, leishmaniasis, and schistosomiasis, among others. Tropical Disease Drugs are typically developed by pharmaceutical companies, universities, and research institutes, and are often funded by public and private organizations. The Tropical Disease Drug market is characterized by a lack of investment and research, due to the fact that these diseases primarily affect low-income countries. This has led to a lack of new treatments and a reliance on existing drugs, many of which are decades old. Despite this, there has been some progress in recent years, with new drugs and treatments being developed. Some of the companies in the Tropical Disease Drug market include GlaxoSmithKline, Novartis, Sanofi, Merck, and Pfizer. Other companies, such as the Medicines for Malaria Venture, are dedicated to researching and developing treatments for tropical diseases. Show Less Read more